Darling Ingredients (DAR)
(Delayed Data from NYSE)
$38.87 USD
-0.71 (-1.79%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $38.85 -0.02 (-0.05%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Price, Consensus and EPS Surprise
DAR 38.87 -0.71(-1.79%)
Will DAR be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for DAR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DAR
Compared to Estimates, Darling (DAR) Q2 Earnings: A Look at Key Metrics
Darling Ingredients (DAR) Q2 Earnings Top Estimates
DAR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Mondelez (MDLZ) Reports Next Week: Wall Street Expects Earnings Growth
Earnings Preview: Darling Ingredients (DAR) Q2 Earnings Expected to Decline
Implied Volatility Surging for Darling Ingredients (DAR) Stock Options
Other News for DAR
Darling Ingredients Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Darling Ingredients: A Hold Rating Amidst Modest Growth and Valuation Concerns
Aristotle Large Cap Growth Q2 2024 Commentary
Aristotle Focus Growth Q2 2024 Commentary
Buy Rating Affirmed for Darling Ingredients with Positive Outlook on EBITDA Growth and SAF Initiatives